Discover how Bio-Rad's bioanalytical services and SpyTag-SpyCatcher technology can speed up custom antibody generation and improve assay flexibility for challenging targets.

Join us as we explore the evolving field of pharmacokinetic (PK) and anti-drug antibody (ADA) assays. In this webinar, Dr. Renee Brissette discusses advancements in bioanalytical antibody development and delve into strategies for ensuring high-quality, reproducible results.

Our discussion features the innovative SpyTag-SpyCatcher technology and its role in improving immunoassay flexibility, and shed light on why recombinant antibodies have become integral for the industry.

Key Topics Include:

  • Understanding the latest advancements and solutions for custom antibody generation
  • Exploring the importance of recombinant antibodies in the industry
  • Delving into the benefits of SpyTag-SpyCatcher in improving assay flexibility
  • Strategies for tackling challenging targets with highly specific bioanalytical antibodies


HuCAL Technical Sales Specialist
Bio-Rad Laboratories

Renee Brissette is a HuCAL Technical Sales Specialist at Bio-Rad Laboratories (USA), having joined the team in 2017. In her current role, she is responsible for designing and delivering high performance custom antibodies using the HuCAL technology. Previous to Bio-Rad, Renee worked at DGI Biotechnologies where she constructed antibody and peptide phage display libraries and developed panning strategies to generate drug leads against novel cancer targets. Renee received her PhD in biochemistry from UMDNJ-New Jersey Medical School (USA) then studied model signal transduction and transcriptional regulator systems in bacteria at Rutgers Medical School (USA) as a postdoctoral fellow. This research led to several significant publications to elucidate the mechanism of signal transduction across membranes by demonstrating the functionality of a chimeric receptor in bacteria.

Production Partner


Bio-Rad is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, our products advance the discovery process and improve healthcare. Our customers include university and research institutions, hospitals, public health and commercial laboratories, biotechnology, pharmaceutical, as well as applied laboratories that include food safety and environmental quality.

Additional Content From Bio-Rad

Additional Content From

Related Content

Rethink your Impurity Analysis Strategy

Rethink your Impurity Analysis Strategy

In this webinar, Dr. Ejvind Mørtz discusses the benefits and applications of mass spectrometry (MS)-based host cell protein (HCP) analysis and why HCP ELISAs are insufficient for documenting product-related impurities. Watch to learn where to apply the assay in a typical process and what you gain from deploying it to your workflow.